DISPOSAL OF CONTROLLED SUBSTANCES
|
|
|
- Byron Parker
- 9 years ago
- Views:
Transcription
1 DISPOSAL OF CONTROLLED SUBSTANCES
2 WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association
3 Outline of Today s 2/2/2 PRESENTER Jan Harris Director, EHS Customer Compliance Sharps Compliance
4 Management of Unused Patient Dispensed Medications Merging the Sharps TakeAway with the Sharps MedSafe Program June 10, 2014
5 Bloodborne Pathogens Training Jan Harris, MPH Director, Environmental, Health & Safety Sharps Compliance
6 In the U.S. Approximately 4 billion prescriptions are filled in the United States annually 35% of the dispensed medication goes unused Over 250 million pounds disposed of improperly
7 Unused Patient Medication Flushing unused patient medications down the toilet or sink can contaminate ground and drinking water Waste water treatment plants ill-equipped Improper disposal into the trash may lead to accidental ingestion and leaching from landfills Unintended ingestion by children or pets can also occur Prescription drug abuse is on the rise
8 The IPA Current Program
9 2005 Iowa Regulatory Environment In 2005 Iowa State Legislature passed House File Prescription Drug Donation Repository Program Authorizes medical facilities and pharmacies to redispense prescription drugs and supplies that would otherwise be destroyed.
10 2007 Federal Regulatory Environment February, 2007, FDA worked with the White House Office of National Drug Control Policy (ONDCP) to develop the first consumer guidance for proper disposal of prescription drugs: Follow any specific disposal instructions Do not flush prescription drugs unless instructed you to do so Kitty litter and trash Take advantage of community drug take-back programs Scratch out identifying information Do not share drugs When in doubt about proper disposal, talk to your pharmacist.
11 2009 State of Iowa and IPA How did the TakeAway Environmental Return System program come into being? Senate File 467 signed into law Pharmacy-based pharmaceutical collection and disposal pilot program. A $165,000 grant from the Iowa Department of Natural Resources was awarded to the Iowa Board of Pharmacy Implemented and administered by Iowa Pharmacy Association and Sharps Environmental Services, Inc.
12 TakeAway Environmental Return Systems
13 TakeAway Capabilities Unique operational agreement with USPS for envelopes Boxes shipped through UPS Tracked, validated and measurable results Process Handled by licensed law enforcement officials Securely stored (packaging is never opened) Weight and date stamped Witnessed and assured destruction No controls allowed
14 IPA Program
15 Secure & Responsible Drug Disposal Act of 2010 Controlled substances are 5 to 10% of medications collected, but are the larger problem Currently, long term care facilities (LTCF) can only dispose of controlled substances through Reverse Distributors or by destroying onsite Retail pharmacies cannot take back controlled substances from ultimate users Act allows for Take-back events (must include law enforcement) Mail-back programs (certain situations) Collection receptacles (certain locations)
16 2012 Proposed Change to 21 CFR Part CFR part 1300 regulations Can deliver unused portions of controlled substances to another entity for destruction without DEA registration if The person receiving controlled substance is authorized The drug is disposed of in accordance with regulations issued by the Attorney General. Finalized rule requirements from the DOJ/ DEA expected June, 2014
17 MedSafe and TakeAway Envelopes The Sharps Compliance Solutions MedSafe Onsite Collection Receptacle Mailback Envelope
18 MedSafe Pharmacy Collection Receptacle Collection Receptacle Inner Liner
19 Replaces the TakeAway boxes Collection Receptacle 14-gauge powder-coated steel construction Two locks secure main door One-way medicine drop with lock Removable, shipback Inner Liner Ships fully assembled with an Inner Liner, two padlocks and keys for the 3 locks Low maintenance Secures to floor or wall Signage for ultimate user instructions Collection instructions on inside of door Currently undergoing security testing to UL 291
20 Inner Liner Cost-effective pre-paid return via common carrier Traceable with unique barcode Includes all components to package for return Modeled after popular 20-Gallon TakeAway Environmental Return System Footprint similar (slightly larger) Meets pending DEA regulations for both non-controlled and controlled drug collection and removal for destruction
21 The Process MedSafe receptacle is placed visible to pharmacy counter Signage and marketing materials instruct ultimate users what to place into receptacle Customer places controls and non-controls into receptacle not taken by pharmacist Shipped UPS or picked up when full Never opened or sorted
22 TakeAway Envelopes and the New DEA Regulations Mailback envelopes will still be utilized A few adjustments will be made to current envelope Provided to ultimate users at the pharmacy counter to be taken home, filled and mailed
23 Same as TakeAway SharpsTracer Tracking Capabilities Secure, proprietary online data warehouse, unique for each client. Outbound inventory Returned inventory Date of return Condition of return Weight of return Current status of return (stored) Date of destruction Effectiveness check Number of scripts returned 7/24 access Availability of customized reporting
24 MedSafe - Marketing Materials 4-page full color brochure 4-page pdf brochure ( ) PI Sheet Promotional slick
25 Resources Disposal of Controlled Substances Proposed Rule: NACDS and NCPA comments on DEA regulations: Sharps:
26 MEDICAL CANNABIS ACROSS THE UNITED STATES Questions? Contact Laura Miller at or
Title 16. Board of Pharmacy Proposed Text
Title 16. Board of Pharmacy Proposed Text Proposal to add new Article 9.1 of Division 17 of Title 16 of the California Code of Regulations and a new Article title as follows: Article 9.1. Prescription
Disposal of Pharmaceuticals, and their empty containers, in the Workplace
Disposal of Pharmaceuticals, and their empty containers, in the Workplace Prepared by Bio-Team Mobile LLC There is a lot of misinformation being circulated about disposal of pharmaceuticals ever since
Statement of Mary L. Hendrickson,PharmD,MBA,RAC Director of Quality & Regulatory Affairs Capital Returns Inc., d/b/a Genco Pharmaceutical Services
Statement of Mary L. Hendrickson,PharmD,MBA,RAC Director of Quality & Regulatory Affairs Capital Returns Inc., d/b/a Genco Pharmaceutical Services Before The Special Committee on Aging United States Senate
A safe return and reuse protocol in the community pharmacy setting may include, but is not limited to, the following elements:
National Association of Boards of Pharmacy Position Statement on the Return and Reuse of Prescription Medications in the Community Pharmacy Setting July 2009 The National Association of Boards of Pharmacy
The Future of Pharmaceutical Waste Regulation. Elise Paeffgen Senior Associate Alston & Bird LLP
The Future of Pharmaceutical Waste Regulation Elise Paeffgen Senior Associate Alston & Bird LLP Issue/Problem Pharmaceuticals in municipal drinking water Sources: Human ingestion/excretion Flushed pharmaceutical
USE OF CONTROLLED SUBSTANCES AN OVERVIEW FOR RESEARCHERS
USE OF CONTROLLED SUBSTANCES AN OVERVIEW FOR RESEARCHERS APPLICABILITY (WITH REGARD TO CONTROLLED SUBSTANCES) This presentation is applicable to: Animal and non-animal research This presentation is mostly
Drug Take-back Programs: Safe Disposal of Unused, Expired, or Unwanted Medications in North Carolina
Drug Take-back Programs: Safe Disposal of Unused, Expired, or Unwanted Medications in North Carolina Prepared for: Coastal Coalition for Substance Abuse Prevention Prepared by: Tanya Elaine Simons 10 October,
Creating Secure Medicine Return Programs to Reduce Misuse of Medicines in King County & Washington State
WEST VIRGINIA INTEGRATED BEHAVIORAL HEALTH CONFERENCE Creating Secure Medicine Return Programs to Reduce Misuse of Medicines in King County & Washington State Margaret Shield, PhD, Policy Liaison Local
Conflicts of Interest. Disposal of Pharmaceutical Waste: What a Technician. Who is interested in proper pharmaceutical waste disposal?
Conflicts of Interest Disposal of Pharmaceutical Waste: What a Technician Should Know Presented by Michael McEvoy Pharm.D. NorthShore University HealthSystem The speaker has nothing to disclose in relation
DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS
DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS (By authority conferred on the director of the department of licensing and
3341-7-09 Use of Controlled Substances in Research.
3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible
Safe Disposal of Unused Controlled Substances/
Safe Disposal of Unused Controlled Substances/ Current Challenges and Opportunities for Reform Prepared for: King Pharmaceuticals, Inc. Prepared by: Sharon Siler Suzanne Duda Ruth Brown Josette Gbemudu
EPA s proposed hazardous waste pharmaceutical regulations
EPA s proposed hazardous waste pharmaceutical regulations November 4, 2015 By J. Timothy Ramsey The United States Environmental Protection Agency ( EPA ) published proposed regulations in the Federal Register
PHARMACEUTICAL WASTE UPDATE ON HANDLING AND DISPOSAL ASTSWMO MEETING August 11, 2011
PHARMACEUTICAL WASTE UPDATE ON HANDLING AND DISPOSAL ASTSWMO MEETING August 11, 2011 Pharmaceutical Waste Getting the attention it deserves Are there Federal, State and Local laws & regulations to comply
UTCVM PHARMACY STANDARD OPERATING PROCEDURES
UTCVM PHARMACY STANDARD OPERATING PROCEDURES Updated: 4/5/2004 I. General Procedures A. Hours: The Pharmacy will be open Monday through Friday, 8:00AM to 6:00PM; Saturday 8:00AM to 1:00PM. The Pharmacy
Report of the Task Force on Drug Return and Reuse Programs
Report of the Task Force on Drug Return and Reuse Programs Members Present: Ron Klein (VT), chair; Lois Anderson (LA); Phil Burgess (IL); Trish D Antonio (DC); Benjamin Fry (TX); Bob Goetz (MN); Suzan
Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY
2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...
Drugs in Our Drinking Water
Drugs in Our Drinking Water What do we do with unused medicines? By Susan Q. Stranahan February 27, 2009 Photo: Getty Images Millions of Americans are drinking water laced with minute quantities of drugs,
Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED
Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED INVESTOR PRESENTATION NOVEMBER Safe Harbor These slides contain (and the accompanying oral discussion will contain)
Reverse Distribution: An Intersection of Regulations Charlotte A. Smith, Senior Regulatory Advisor, PharmEcology Services, WM National Services, Inc.
Reverse Distribution: An Intersection of Regulations Charlotte A. Smith, Senior Regulatory Advisor, PharmEcology Services, WM National Services, Inc. Legal Disclaimer This course is solely for educational
247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
1083.4 SUPPLY CHAIN INTEGRITY AND SECURITY
BRIEFING 1083.4 Supply Chain Integrity and Security. A new series of general informational chapters describing various aspects of the pharmaceutical supply chain replaces Good Distribution Practices Supply
UW School of Dentistry Comprehensive Medication Policy
UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides
Managing Pharmaceutical Waste at the LTC Provider Pharmacy
Managing Pharmaceutical at the LTC Provider Pharmacy Is your pharmacy compliant with all regulations related to pharmaceutical waste? The long-term care (LTC) industry is currently faced with the simultaneous
PREP WORKSHOP #11 Investigational Drug Disposal
PREP WORKSHOP #11 Investigational Drug Disposal Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, Clinical Research Service Miyuki Yoshida-Hay, RSO, MLSO, CHSP Safety Office,
American Society of Consultant Pharmacists Background
American Society of Consultant Pharmacists 1321 Duke St. Alexandria, VA 22314-3563 Phone: 703-739-1300 FAX: 703-739-1321 E-mail: [email protected] www.ascp.com March 4, 2009 RCRA Docket Environmental Protection
Investigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
ARKANSAS. Downloaded January 2011
ARKANSAS Downloaded January 2011 302 GENERAL ADMINISTRATION 302.11 Pharmacies operated in nursing homes shall be operated in compliance with Arkansas laws and shall be subject to inspection by personnel
NH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
VERMONT2007. Drugs and Medical Supply Repository Study. Report to the Legislature on Act 139 Sec. 6 Report Relating to 8 V.S.A. 107 January 15, 2007
VERMONT2007 Drugs and Medical Supply Repository Study Report to the Legislature on Act 139 Sec. 6 Report Relating to 8 V.S.A. 107 108 Cherry Street, PO Box 70 Burlington, VT 05402 1.802.951.1258 healthvermont.gov
Safe Disposal of Medications and Sharps in the Home Setting. American Nurses Association & U.S. Food and Drug Administration
Safe Disposal of Medications and Sharps in the Home Setting American Nurses Association & U.S. Food and Drug Administration Objectives: Identify the potential human and environmental hazards of sharps
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
Narcotic Treatment Programs
This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act
Biohazardous Waste and Sharps Disposal
Biohazardous Waste and Sharps Disposal Federal OSHA Occupational Exposure to Bloodborne Pathogens Standard 29 CFR 1910.1030 State California Code of Regulations (CCR), Medical Waste Management Act, Chapter
STANDARD OPERATING PROCEDURE #401 CONTROLLED SUBSTANCES
STANDARD OERATING ROCEDURE #401 CONTROLLED SUBSTANCES 1. UROSE This Standard Operating rocedure (SO) describes procedures for acquiring, storing, using and discarding controlled substances. 2. RESONSIBILITY
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2006 Compliance
Guidance for Industry Prescription Drug Marketing Act Donation of Prescription Drug Samples to Free Clinics U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist
IHS National Prescription Drug Abuse Workgroup
IHS National Prescription Drug Abuse Workgroup A Report to the National Combined Councils June 25, 2014 IHS PDA Workgroup - History Director was approached in Jan 2012 at NCC by NCCMO regarding PDA epidemic
Management of Pharmaceutical Wastes from Healthcare & Households. Rudy Vingris Product Manager PharmEcology Services Waste Management, Inc.
Management of Pharmaceutical Wastes from Healthcare & Households Rudy Vingris Product Manager PharmEcology Services Waste Management, Inc. Legal Disclaimer This presentation is solely for educational purposes
Administrative Policy
Administrative Policy Number: 411 Effective: 4/7/2011 Supersedes: n/a Page: 1 of 8 Subject: Use of Controlled Substances in Research 1.0. PURPOSE: The purpose of this policy is to set forth procedures
ARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:
ARKANSAS PRODUCTS: Any product containing ephedrine, pseudoephedrine, or phenylpropanolamine or any of their salts, isomers, or salts of isomers, alone or in a mixture. (A.C.A. 5-64-212) PRODUCT EXEMPTIONS:
Pharmaceutical Waste Initiatives: What Comes Next? ACPE # 0206-0000-12-601-L05-P (0.1 CEU)
Date: Monday, August 27, 2012 Time: 10:15 a.m. 11:15 a.m. Location: Colorado Convention Center Rooms 111-113 Title: Speaker: Pharmaceutical Waste Initiatives: What Comes Next? ACPE # 0206-0000-12-601-L05-P
Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)
Initial REMS approval: 02/2013 Most recent modification: 06/2015 Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) This REMS applies
RULE. The Administration of Medication in Louisiana Public Schools
RULE The Administration of Medication in Louisiana Public Schools Developed in 1994 by The Louisiana State Board of Elementary and Secondary Education and The Louisiana State Board of Nursing Amendments
Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs
Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Charlesworth Rae, BS, PharmD, JD Investigational Drug Pharmacist July 2012 1 Outline of Presentation I. Introduction
Compliance Bulletin Solid Waste Medical Waste Treatment reviewed/revised February 2012
Compliance Bulletin Solid Waste Medical Waste Treatment reviewed/revised February 2012 Medical waste can be divided into two basic types for treatment purposes: 1) infectious wastes like blood and body
CONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
IMP management at site. Dmitry Semenyuta
IMP management at site Dmitry Semenyuta TOP 5 FDA inspections finding 1999-2009 Center of Drug Evaluation and Research (CDER) Failure to follow the protocol Failure to keep adequate and accurate records
2013 -- H 5230 S T A T E O F R H O D E I S L A N D
======= LC00 ======= 01 -- H 0 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO HEALTH AND SAFETY - THE RETURN OR EXCHANGE OF DRUGS ACT Introduced
Hazardous Pharmaceutical Waste Management. Written by: Matthew Teeter, Environmental Compliance Consultant
Hazardous Pharmaceutical Waste Management Written by: Matthew Teeter, Environmental Compliance Consultant Identifying Hazardous Pharmaceuticals Certain pharmaceuticals used in hospitals, medical centers
Review of Maine Pharmacy Rules. An update of new rules adopted 12/11/2013
Review of Maine Pharmacy Rules An update of new rules adopted 12/11/2013 This review is meant to highlight important changes and additions to the rules as adopted on 12/11/2013. We will cover the rules
Track/Trace Solutions. for the Manufacturing Industry
Track/Trace Solutions for the Manufacturing Industry Today s manufacturers, regardless of what they produce, have no choice but to follow private sector and government required mandates. As examples, two
Table of Contents. 2 P a g e
Table of Contents Introduction... 3 Important Contact Information... 3 Pharmacy Rights... 3 Claims Adjudication... 3 Reversals... 4 Required Data Fields... 4 Identification cards... 4 Required Identification
Eight Important Principles For Managing Prescription Medications In the Athletic Training Room
Eight Important Principles For Managing Prescription Medications In the Athletic Training Room Robert Nickell, RPh, FAPO, FCPHA, FACA Sports Pharmacist USA Team Pharmacist President and CEO, Sportpharm
Pharmaceutical Waste Management Program St. Joseph Mercy Oakland. Pharmacy/Patient Care
Pharmaceutical Waste Management Program St. Joseph Mercy Oakland Pharmacy/Patient Care Objectives Understand the background and regulatory requirements Identify pharmaceutical waste and how to dispose
Guidance for Industry
Guidance for Industry Toll-Free Number Labeling and Related Requirements for Over-the-Counter and Prescription Drugs Marketed With Approved Applications Small Entity Compliance Guide U.S. Department of
DEA REGISTRATION FEES FACT SHEET
DEA REGISTRATION FEES FACT SHEET Summary On April 16, 2012,the Drug Enforcement Administration (DEA) will implement an adjustment to the fees it charges to DEA registrants. For the vast majority of registrants
Planning Issues for Hospital Pharmacies with Growing Outpatient Populations
Planning Issues for Hospital Pharmacies with Growing Outpatient Populations In recent years, there has been an increasing emphasis in healthcare on the provision of ambulatory care services. It is predicted
Louisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists
Chapter 17. Institutional Pharmacy Louisiana Administrative Code Title 46 Professional and Occupational Standards Subchapter A. General Requirements Part LIII: Pharmacists 1701. Cross References A. For
Be it enacted by the People of the State of Illinois,
AN ACT concerning safety. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 3. The Department of Public Health Powers and Duties Law of the Civil Administrative
The Comprehensive Environmental Response,
Purpose and Applicability of Regulations The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) was enacted by Congress in 1980 to clean up the nation s hazardous waste sites
BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY:
BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: About the report About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country s leading innovative
UCSD Controlled Substances Program Procedures
UCSD Controlled Substances Program Procedures I. PROCEDURE A. Controlled Substance Use Authorization Requirements A Controlled Substance Use Authorization (CSUA) must be completed prior to acquiring controlled
Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
Technical Information Paper No. 37-016-0513. REFERENCES. See Appendix A for a list of reference information.
Resources for Evaluating Medical Waste Treatment Technologies Technical Information Paper No. 37-016-0513 PURPOSE. To provide guidance and references for a public health evaluation of the effectiveness
Pharmaceutical Waste Compliance Program
Pharmaceutical Waste Compliance Program Corporate Overview Stericycle Services Medical Waste Management Sharps Disposal Management Product Recalls & Retrieval OSHA Compliance Training Pharmaceutical &
